CLINICAL_TRIALS
trial_result
· 2014-10-09
Clinical Trial Update: Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TORA) [Phase 2]
Summary
Phase 2 trial evaluating the effect of tolvaptan on the nitric oxide system in cardiovascular diseases and nephropathy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regional Hospital Holstebro | Conditions: Cardiovascular Diseases, Nephropathy | Phase 2 | Status: COMPLETED